On June 26, Meituan-W declined 3.33% in regular trading, trading at HK$64.0/share, with turnover of HK$4.071 billion. The stock touched a fresh one-year low, extending its slide from the previous session.

The decline was primarily driven by a broad selloff across Hong Kong markets that weighed heavily on technology stocks. Despite management delivering supportive commentary at the annual general meeting — CEO Wang Xing acknowledged deep responsibility for the weak share price and called for rational industry development, while CFO Chen Shaohui stated the company is severely undervalued and announced plans for share buybacks — the positive signals failed to offset the prevailing market weakness.

Meituan shares had already fallen to HK$64.75 on June 25, marking a one-year low. The company's market capitalization has shrunk by nearly HK$100 billion from its February high. Within the Internet and Direct Marketing Retail sector, peers also saw broad declines: BABA-W down 6.32%, JD-SW down 2.84%, Ali Health down 4.08%, JD Health down 3.92%, and PA GoodDoctor down 3.38%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)